{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:22:32Z","timestamp":1791285752244,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873470"],"award-info":[{"award-number":["81873470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115380","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T23:03:58Z","timestamp":1693091038000},"page":"115380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Regulatory mechanism of CaMKII \u03b4 mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872"],"prefix":"10.1016","volume":"166","author":[{"given":"Jingjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-9879","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"847362","key":"10.1016\/j.biopha.2023.115380_bib1","article-title":"Ca2+\/Calmodulin-dependent protein kinase II regulation by RIPK3 alleviates necroptosis in transverse arch constriction-induced heart failure","volume":"28","author":"Cao","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2023.115380_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2023.115380_bib3","doi-asserted-by":"crossref","first-page":"10.4045","DOI":"10.4045\/tidsskr.17.1027","article-title":"Myocardial fibros","volume":"138","author":"Espeland","year":"2018","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.biopha.2023.115380_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/metabo12040297","article-title":"Extracellular matrix in heart disease: focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: a concise review","volume":"12","author":"Nikolov","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2023.115380_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ejhf.312","article-title":"Searching for new mechanisms of myocardial fibrosis with diagnostic and\/or therapeutic potential","volume":"17","author":"Heymans","year":"2015","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2023.115380_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","article-title":"Necroptosis in the pathophysiology of disease","volume":"190","author":"Khoury","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2023.115380_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2023.115380_bib8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/cells10092397","article-title":"MLKL and CaMKII are involved in RIPK3-mediated smooth muscle cell necroptosis","volume":"9","author":"Zhou","year":"2021","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.biopha.2023.115380_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"vol","author":"Zhang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.115380_bib10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2023.115380_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.matbio.2022.08.005","article-title":"RIPK3-MLKL signaling activates mitochondrial CaMKII and drives intrarenal extracellular matrix production during CKD","volume":"112","author":"Srivastava","year":"2022","journal-title":"Matrix Biol."},{"key":"10.1016\/j.biopha.2023.115380_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41419-022-04587-1","article-title":"RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts","volume":"13","author":"Qiao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115380_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00395-018-0688-8","article-title":"Physiological and unappreciated roles of CaMKII in the heart","volume":"113","author":"Beckendorf","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2023.115380_bib14","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca2+\/calmodulin-dependent protein kinase II \u03b4 signaling in cardiomyocytes are essential for adverse cardiac remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115380_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes","volume":"vol. 70","author":"Bers","year":"2008","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2023.115380_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2019.01.001","article-title":"CaMKII signaling in heart diseases: emerging role in diabetic cardiomyopathy","volume":"127","author":"Hegyi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2023.115380_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102487","article-title":"RGS11-CaMKII complex mediated redox control attenuates chemotherapy-induced cardiac fibrosis","volume":"57","author":"Das","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115380_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.115380_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14728222.2022.2031974","article-title":"Emerging therapeutic targets for cardiac hypertrophy","volume":"26","author":"Winkle","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115380_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/CIRCULATIONAHA.121.055920","article-title":"Novel CaMKII-\u03b4 inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia\/reperfusion injury and inhibit tumor growth","volume":"145","author":"Zhang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115380_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-019-0380-8","article-title":"CaMKII-\u03b49 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair","volume":"21","author":"Zhang","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115380_bib22","article-title":"CaMKII\u03b4 splice variants in the healthy and diseased heart","volume":"9","author":"Javier","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2023.115380_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crphys.2019.10.001","article-title":"Cardiac hypertrophy or failure?- A systematic evaluation of the transverse aortic constriction model in C57BL\/6NTac and C57BL\/6J substrains","volume":"1","author":"Zi","year":"2019","journal-title":"Curr. Res. Physiol."},{"key":"10.1016\/j.biopha.2023.115380_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.886553","article-title":"Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target","volume":"9","author":"Schimmel","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2023.115380_bib25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/pharmaceutics14081599","article-title":"Targeting myocardial fibrosis-a magic pill in cardiovascular medicine?","volume":"14","author":"Scridon","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115380_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"and KatjaSchenke-Layland.\"Cardiac fibrosis - a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115380_bib27","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/biom12111674","article-title":"Osteoglycin: an ECM factor regulating fibrosis and tumorigenesis","volume":"12","author":"Nulali","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.115380_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bcp.2014.04.011","article-title":"Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors","volume":"90","author":"Spinale","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115380_bib29","doi-asserted-by":"crossref","first-page":"23081","DOI":"10.1038\/s41598-021-02508-4","article-title":"Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis","volume":"11","author":"Kremastiotis","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115380_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57920","article-title":"Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP\/TGF\u03b21 after myocardial infarction","volume":"9","author":"Alonso-Herranz","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2023.115380_bib31","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/HJH.0000000000002504","article-title":"Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease","volume":"38","author":"Pichler","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2023.115380_bib32","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.3390\/ijms222212341","article-title":"Exercise training alleviates cardiac fibrosis through increasing fibroblast growth factor 21 and regulating TGF-\u03b21-Smad2\/3-MMP2\/9 signaling in mice with myocardial infarction","volume":"22","author":"Ma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115380_bib33","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/cells10071716","article-title":"Cardiac fibrosis and fibroblasts","volume":"10","author":"Kurose","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115380_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","article-title":"Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches","volume":"18","author":"L\u00f3pez","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2023.115380_bib35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2217\/bmm-2020-0298","article-title":"Role of collagen turnover biomarkers in the noninvasive assessment of myocardial fibrosis: an update","volume":"14","author":"Ureche","year":"2020","journal-title":"Biomark. Med."},{"key":"10.1016\/j.biopha.2023.115380_bib36","doi-asserted-by":"crossref","first-page":"6635955","DOI":"10.1155\/2021\/6635955","article-title":"RIPK3 induces cardiomyocyte necroptosis via inhibition of AMPK-parkin-mitophagy in cardiac remodelling after myocardial infarction","author":"Zhu","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2023.115380_bib37","first-page":"134","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation.","volume":"20","author":"Duan","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115380_bib38","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.3390\/ijms232112714","article-title":"Necroptosis: a pathogenic negotiator in human diseases","volume":"23","author":"Chaouhan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115380_bib39","doi-asserted-by":"crossref","first-page":"1032614","DOI":"10.3389\/fendo.2022.1032614","article-title":"Necroptosis: a new target for prevention of osteoporosis","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"286\u2013300","key":"10.1016\/j.biopha.2023.115380_bib40","article-title":"ESCRT-III Acts downstream of MLKL to regulate necroptotic cell death and its consequences","volume":"169","author":"Gong","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115380_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.668129","article-title":"CaMKII in regulation of cell death during myocardial reperfusion injury","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2023.115380_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/15548627.2021.1954348","article-title":"CAMK2\/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux","volume":"18","author":"Zhan","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2023.115380_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104815","article-title":"Neurogranin regulates calcium-dependent cardiac hypertrophy","volume":"127","author":"Jorgensen","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2023.115380_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/FJC.0000000000000512","article-title":"CaMKII Activation promotes cardiac electrical remodeling and increases the susceptibility to arrhythmia induction in high-fat diet-fed mice with hyperlipidemia conditions","volume":"70","author":"Zhong","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115380_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14728222.2021.1849145","article-title":"Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function","volume":"25","author":"Patel","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115380_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97054","article-title":"CaMKII\u03b4-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis","volume":"3","author":"Willeford","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.115380_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13541","article-title":"The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury","volume":"231","author":"Ying","year":"2021","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.biopha.2023.115380_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7150\/ijbs.65402","article-title":"RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism","volume":"18","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115380_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.014","article-title":"Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation","volume":"103","author":"Guo","year":"2019","journal-title":"J. Autoimmun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:46:28Z","timestamp":1782369988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223011770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"alternative-id":["S0753332223011770"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115380","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory mechanism of CaMKII \u03b4 mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115380"}}